Hepatitis C Virus Treatment: Simplifying the Simple and Optimizing the Difficult

Research output: Contribution to journalArticlepeer-review


The availability of safe, efficacious, oral direct-acting antivirals (DAAs) have ushered in a new era of hepatitis C treatment with potential to eliminate hepatitis C as a public health threat. To achieve population-level effectiveness of these oral DAAs, hepatitis C treatment by a wide range of providers in different settings will be essential to increase the number of persons treated. We provide a clinical review of hepatitis C treatment with a focus on practical tools for management of hepatitis C in majority of currently infected individuals who can be easily cured and optimization of treatment for those in whom treatment may not be as simple.

Original languageEnglish (US)
Pages (from-to)S745-S757
JournalThe Journal of infectious diseases
StatePublished - Nov 27 2020


  • hepatitis C
  • oral direct-acting antivirals
  • treatment

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases


Dive into the research topics of 'Hepatitis C Virus Treatment: Simplifying the Simple and Optimizing the Difficult'. Together they form a unique fingerprint.

Cite this